Angiosarcoma Awareness
Angiosarcoma Awareness is a patient-driven nonprofit that raises funds for laboratories and research initiatives that focus on angiosarcoma. Through their funding, they aim to support better therapies and research for a cure.
Imerman Angels
We’ve teamed up with Imerman Angels to ensure that people facing sarcoma have the opportunity to give or receive one-on-one support. Imerman Angels provides personalized connections that enable one-on-one support among people affected by any type of cancer—at any stage, age, or location. Through their unique matching process, they connect people with a “Mentor Angel,” a cancer survivor or caregiver who has experienced the same type of cancer.
National Organization for Rare Diseases (NORD)
The National Organization for Rare Disorders (NORD) is a federation of voluntary health organizations dedicated to helping people with rare orphan diseases and assisting the organizations that serve them. NORD is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service.
Sarcoma Foundation of America
(Our Sister Site)
The mission of the Sarcoma Foundation of America (SFA) is to advocate for increased research to find new and better therapies with which to treat patients with Sarcoma. The organization raises money to privately fund grants for sarcoma researchers and conducts education and advocacy efforts on behalf of Sarcoma patients.
Wendy Walk
An organization dedicated to advancing sarcoma research, Wendy Walk funds treatment-focused research projects across the globe. Each year, the organization hosts walks in Los Angeles, Miami, and New York to raise funds and awareness for sarcoma research.
The Desmoid Tumor Research Foundation (DTRF)
The DTRF aggressively funds desmoid tumor research, accelerates the development of improved therapies, drives collaborations among clinicians and researchers worldwide, and supports patients and doctors through education. Our goal is to find a cure for each and every patient diagnosed with this rare disease.
Corporate Partners
